共 28 条
- [21] Discovery and characterization of ABSK071, a novel and potent small-molecule covalent inhibitor for KRAS-G12CEUROPEAN JOURNAL OF CANCER, 2022, 174 : S22 - S23Guo, F.Zhao, Y.Yu, H.Xu, Y.Chen, Z.Yang, S.
- [22] Preclinical characterization of D3S-001, a highly potent, selective, and differentiated covalent inhibitor of KRAS G12C.JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)Zhang, JingWu, WentaoXu, YangyangQian, YiXia, YuanfengLu, JiangZheng, ZhiqiangLu, JingtaoChen, JanetChen, ChaseWang, JiaChen, ChengRui, HaopengWang, AllisonJin, JohnChen, Zhi Jian
- [23] A phase 1 trial evaluating the safety, tolerability, PK, and preliminary efficacy of QTX3034, an oral G12D-preferring multi-KRAS inhibitor, in patients with solid tumors with KRASG12D mutation.JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Patnaik, AmitaPelster, MeredithHong, David S.Strickler, John H.Garrido-Laguna, IgnacioAguirre, AndrewCurran, DominicWoo, TinaSpira, Alexander I.
- [24] Preclinical characterization of HBW-012-E, a novel, potent, selective, safe, and orally active KRAS G12D inhibitor with superior pharmacokinetic (PK) properties and anti-tumor efficacyJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Lee, NingLi, YingfuLiu, GuanfengLi, JiangRen, Junfeng
- [25] Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted CancersJOURNAL OF MEDICINAL CHEMISTRY, 2025,Cregg, JamesEdwards, Anne V.Chang, StephanieLee, Bianca J.Knox, John E.Tomlinson, Aidan C. A.Marquez, AbbyLiu, YangFreilich, RebeccaAay, NaingWang, YingyunJiang, LingyanJiang, JingjingWang, ZhicanFlagella, MichaelWildes, DavidSmith, Jacqueline A. M.Singh, MallikaWang, ZhengpingGill, Adrian L.Koltun, Elena S.
- [26] VEGFR inhibitor AV-951 exhibits potent anti-angiogenic and antitumor activity in engineered Kras G12V and in EGFRL858R/T790M TKI resistant lung adenocarcinomasJOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S549 - S550Lin JieYang HongmeiSun XiaojianZhou YinghuiHeyer, JoergRideout, I. I. I. William M.Bressel, AngelaRobinson, Murray
- [27] Discovery of D-1553, a novel and selective KRas-G12C Inhibitor with potent anti-tumor activity in a broad spectrum of tumor cell lines and xenograft models.CANCER RESEARCH, 2021, 81 (13)Shi, ZheWeng, JifangFan, XiaochongWang, EmmaZhu, QingqingTao, LiangshanHan, ZixingWang, ZhenwuNiu, HaotaoJiang, YuehengZhang, LingDai, XingWang, Yaolin
- [28] Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT InhibitorJOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (13) : 6455 - 6469Lapierre, Jean-MarcEathiraj, SudharshanVensel, DavidLiu, YanbinBull, Cathy O.Cornell-Kennon, SusanIimura, ShinKelleher, Eugene W.Kizer, Darin E.Koerner, SteffiMakhija, SapnaMatsuda, AkihisaMoussa, MagdiNamdev, NiveditaSavage, Ronald E.Szwaya, JeffVolckova, ErikaWestlund, NeilWu, HuiSchwartz, Brian